Children’s Hospital of Pittsburgh of UPMC Receives $50,000 Childhood Cancer Research Grant from the St. Baldrick’s Foundation
PITTSBURGH, Nov. 14, 2013
– Linda M. McAllister-Lucas, M.D., Ph.D
., chief, Division of Pediatric Hematology/Oncology at Children’s Hospital of Pittsburgh of UPMC
, has been awarded a one-year, $50,000 grant from the St. Baldrick’s Foundation
, a volunteer-driven charity dedicated to raising money for childhood cancer research.
Dr. McAllister’s is one of 39 infrastructure grants
awarded by the Foundation’s fall grant cycle, totaling more than $2.2 million in pediatric oncology research. These grants provide resources to institutions to conduct more research and enroll more children in ongoing clinical trials.
“This grant will allow our program to perform Phase I clinical trials aimed at identifying new and improved treatment options for childhood cancer,” said Dr. McAllister. “Our team has an excellent record of study compliance and patient safety, and the St. Baldrick's grant allows us to support a clinical research nurse on the team.”
Dr. McAllister, also professor of pediatrics at the University of Pittsburgh School of Medicine
, came to Pittsburgh in January 2013, bringing a rich background in research, clinical care and teaching to the hospital, its patients and the university.
“While fewer than 5 percent of adults with cancer participate in clinical trials, more than 60 percent of childhood cancer patients receive their treatment as part of clinical trials, which are designed to offer the best cutting-edge treatments, or treatments that may be even better than today’s standard,” said Kathleen Ruddy, chief executive officer for the St. Baldrick’s Foundation. “The St. Baldrick’s Foundation is proud to fund this latest round of infrastructure grants, many of which will make more clinical trials available for children closer to their homes. This offers today’s patients more hope and tomorrow’s patients more progress through research.”
Children's Hospital of Pittsburgh of UPMC is a member of the Children's Oncology Group
and is one of 13 centers nationwide to be selected as a Phase I research center. Children’s Hospital also is a member of the Pediatric Brain Tumor Consortium
, a select group of institutions with leading neuro-oncology clinical trial capability.
For more information about Dr. McAllister, please visit www.chp.edu